MegaPro

MegaPro Biomedical was awarded the Start-up Award in the 13th National Innovation Award

May 27, 2019 The outstanding core technology of niche nanomedicine, iron oxide nanoparticles developed by “MegaPro Biomedical”, a biotechnology start-up by ITRI, as well as the future nano-micelle drug carrier received the Start-up Award in the 13th National Innovation Award. After its spin-off from ITRI in 2015, the team in MegaPro Biomedical has been actively[…]

MegaPro

MegaPro Biomedical was invited to “The Third China BioMed Innovation and Investment Conference” hosted by PhIRDA

September 14, 2018 Dr. Jassy Wang will represent MegaPro Biomedical in The Third China BioMed Innovation and Investment Conference hosted by PhIRDA in Suzhou. In addition to interacting with the key pharmaceutical, new drug, and medical equipment companies as well as investment organizations in China, she will conduct a special roadshow between 4.40pm and 5[…]

Apexigen

Apexigen and Yale Cancer Center Announce Clinical Collaboration to Evaluate APX005M, Cabiralizumab, and Opdivo (Nivolumab) in Patients whose Disease has Progressed on Anti-PD-1/PD-L1 Therapy

San Carlos, CA, and New Haven, CT – June 14, 2018 Apexigen and Yale Cancer Center today announced a clinical trial collaboration to evaluate Apexigen’s APX005M in combination with cabiralizumab and Opdivo in patients with advanced solid tumors. The Phase 1/2 clinical trial will evaluate the safety, tolerability, and preliminary activity of APX005M in combination with cabiralizumab[…]

Quanergy

Quanergy Wins Silicon Valley Chamber of Commerce Annual Murphy Award

March 19, 2018 Quanergy Systems, Inc., the leading provider of LiDAR sensors and smart sensing solutions, today announced its selection as the recipient of the Silicon Valley Chamber of Commerce’s 2018 Murphy award for Outstanding Innovation in LiDAR Sensing Technology. Issued annually by the Silicon Valley Chamber of Commerce, the award recognizes outstanding accomplishments in[…]